The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Intellia Therapeutics, Inc. NTLA lost 21.6% in a week as investors were disappointed with the company’s plans for portfolio ...

The cause of rare diseases is increasingly being detected through genome sequencing, which involves reading the entire human DNA by first breaking it into small pieces -- short reads. Scientists found ...

William Blair analyst Sami Corwin has maintained their bullish stance on CRSP stock, giving a Buy rating on January 14.Stay Ahead of the ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

The White House is honoring three Iowa State researchers for their work in artificial intelligence, genome editing and ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

Colossal Biosciences, the world's first de-extinction company, has today announced $200M in a Series C financing by TWG ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...